Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2

GLIA

Volumn 54, Issue 5, 2006, Pages 471-483

  Padovani Claudio, Dolly A ^a   Liu, Liping ^b   Ransohoff, Richard M ^b   Miller, Robert H ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Central nervous system; Chemokines; Conduction velocity; Myelination; Oligodendrocyte precursors

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL LINEAGE; CELL MIGRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS CALLOSUM; EVOKED RESPONSE; MOUSE; MYELIN SHEATH; MYELINATION; NERVE CONDUCTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPINAL CORD; WHITE MATTER;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN SHEATH; NERVE FIBERS, MYELINATED; NERVE TISSUE PROTEINS; NERVOUS SYSTEM MALFORMATIONS; NEURAL CONDUCTION; NEURAL PATHWAYS; OLIGODENDROGLIA; RECEPTORS, INTERLEUKIN-8B; STEM CELLS;

EID: 33748857970     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20383     Document Type: Article

References (62)

1. Aust G, Steinert M, Boltze C, Kiessling S, Simchen C. 2001. GRO-α in normal and pathological thyroid tissues and its regulation in thyroid-derived cells. J Endocrinol 170:513-520.
2. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, Raff MC. 1992. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31-46.
3. Barres BA, Lazar MA, Raff MC. 1994. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120:1097-1108.
4. Bosio A, Bussow H, Adam J, Stoffel W. 1998. Galactosphingolipids and axono-glial interaction in myelin of the central nervous system. Cell Tissue Res 292:199-210.
5. Boyle ME, Berglund EO, Murai KK, Weber L, Peles E, Ranscht B. 2001. Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron 30:385-397.
6. Brady ST, Witt AS, Kirkpatrick LL, de Waegh SM, Readhead C, Tu PH, Lee VM. 1999. Formation of compact myelin is required for maturation of the axonal cytoskeleton. J Neurosci 19:7278-7288.
7. Bunge RP. 1968. Glial cells and the central myelin sheath. Physiol Rev 48:197-251.
8. Cacalano G, Lee J, Kikly K, Ryan AM, Pitts-Meek S, Hultgren B, Wood WI, Moore MW. 1994. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265:682-684.
9. Calaora V, Rogister B, Bismuth K, Murray K, Brandt H, Leprince P, Marchionni M, Dubois-Dalcq M. 2001. Neuregulin signaling regulates neural precursor growth and the generation of oligodendrocytes in vitro. J Neurosci 21:4740-4751.
10. Calver AR, Hall AC, Yu WP, Walsh FS, Heath JK, Betsholtz C, Richardson WD. 1998. Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 20:869-882.
11. Calza L, Fernandez M, Giuliani A, Aloe L, Giardino L. 2002. Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during experimental allergic encephalomyelitis. Proc Natl Acad Sci USA 99:3258-3263.
12. Calza L, Fernandez M, Giuliani A, D'Intino G, Pirondi S, Sivilia S, Paradisi M, Desordi N, Giardino L. 2005. Thyroid hormone and remyelination in adult central nervous system: A lesson from an inflammatory-demyelinating disease. Brain Res Brain Res Rev 48: 339-346.
13. Cannella B, Hoban CJ, Gao YL, Garcia-Arenas R, Lawson D, Marchionni M, Gwynne D, Raine CS. 1998. The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis. Proc Natl Acad Sci USA 95:10100-10105.
14. Charo IF, Ransohoff RM. 2006. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354:610-621.
15. Cho C, Miller RJ. 2002. Chemokine receptors and neural function. J Neurovirol 8:573-584.
16. Coughlan CM, McManus CM, Sharron M, Gao Z, Murphy D, Jaffer S, Choe W, Chen W, Hesselgesser J, Gaylord H, Kalyuzhy A, Lee VM, Wolf B, Doms RW, Kolson DL. 2000. Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience 97:591-600.
17. Danik M, Puma C, Quirion R, Williams S. 2003. Widely expressed transcripts for chemokine receptor CXCR1 in identified glutamatergic, γ-aminobutyric acidergic, and cholinergic neurons and astrocytes of the rat brain: A single-cell reverse transcription-multiplex polymerase chain reaction study. J Neurosci Res 74:286-295.
18. de Castro F, Bribian A. 2005. The molecular orchestra of the migration of oligodendrocyte precursors during development. Brain Res Brain Res Rev 49:227-241.
19. Dziembowska M, Tham TN, Lau P, Vitry S, Lazarini F, Dubois-Dalcq M. 2005. A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia 50:258-269.
20. Dziewulska D, Jamrozik Z, Podlecka A, Rafalowska J. 1999. Do astrocytes participate in rat spinal cord myelination? Folia Neuropathol 37:81-86.
21. Fernandez EJ, Lolis E. 2002. Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 42:469-499.
22. Fernandez M, Giuliani A, Pirondi S, D'Intino G, Giardino L, Aloe L, Levi-Montalcini R, Calza L. 2004. Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc Natl Acad Sci USA 101:16363-16368.
23. Filipovic R, Jakovcevski I, Zecevic N. 2003. GRO-α and CXCR2 in the human fetal brain and multiple sclerosis lesions. Dev Neurosci 25:279-290.
24. Flynn G, Maru S, Loughlin J, Romero IA, Male D. 2003. Regulation of chemokine receptor expression in human microglia and astrocytes. J Neuroimmunol 136:84-93.
25. Glabinski AR, Ransohoff RM. 1999. Chemokines and chemokine receptors in CNS pathology. J Neurovirol 5:3-12.
26. Hesselgesser J, Horuk R. 1999. Chemokine and chemokine receptor expression in the central nervous system. J Neurovirol 5:13-26.
27. Horuk R, Martin AW, Wang Z, Schweitzer L, Gerassimides A, Guo H, Lu Z, Hesselgesser J, Perez HD, Kim J, Parker J, Hadley TJ, Peiper SC. 1997. Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 158: 2882-2890.
28. Huising MO, Stet RJ, Kruiswijk CP, Savelkoul HF, Verburg-van Kemenade BML. 2003. Molecular evolution of CXC chemokines: Extant CXC chemokines originate from the CNS. Trends Immunol 24:307-313.
29. Krkpatrick LL, Witt AS, Payne HR, Shine HD, Brady ST. 2001. Changes in microtubule stability and density in myelin-deficient shiverer mouse CNS axons. J Neurosci 21:2288-2297.
30. Lai M, Lewis PD. 1980. Effects of undernutrition on myelination in rat corpus callosum. J Comp Neurol 193:973-982.
31. Laing KJ, Secombes CJ. 2004. Chemokines. Dev Comp Immunol 28: 443-460.
32. Landry CF, Ivy GO, Brown IR. 1990. Developmental expression of glial fibrillary acidic protein mRNA in the rat brain analyzed by in situ hybridization. J Neurosci Res 25:194-203.
33. Lazarini F, Tham TN, Casanova P, Arenzana-Seisdedos F, Dubois-Dalcq M. 2003. Role of the α-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia 42:139-148.
34. Li Q, Shirabe K, Thisse C, Thisse B, Okamoto H, Masai I, Kuwada JY. 2005. Chemokine signaling guides axons within the retina in zebra-fish. J Neurosci 25:1711-1717.
35. Liedtke W, Edelmann W, Bieri PL, Chiu FC, Cowan NJ, Kucherlapati R, Raine CS. 1996. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 17:607-615.
36. -/- mice with experimental autoimmune encephalomyelitis. J Immunol 176(7):4399-4409.
37. Mallon BS, Shick HE, Kidd GJ, Macklin WB. 2002. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J Neurosci 22:876-885.
38. Mathis C, Hindelang C, LeMeur M, Borrelli E. 2000. A transgenic mouse model for inducible and reversible dysmyelination. J Neurosci 20:7698-7705.
39. Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, Role L, Lai C, Schwab MH, Nave KA. 2004. Axonal neuregulin-1 regulates myelin sheath thickness. Science 304:700-703.
40. Miller RJ, Tran PB. 2005. Chemokinetics. Neuron 47:621-623.
41. Neuberg DH, Carenini S, Schachner M, Martini R, Suter U. 1998. Accelerated demyelination of peripheral nerves in mice deficient in connexin 32 and protein zero. J Neurosci Res 53:542-550.
42. Nguyen D, Stangel M. 2001. Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells. Brain Res Dev Brain Res 128:77-81.
43. Noll E, Miller RH. 1993. Oligodendrocyte precursors originate at the ventral ventricular zone dorsal to the ventral midline region in the embryonic rat spinal cord. Development 118:563-573.
44. Omari KM, John G, Lango R, Raine CS. 2005a. Role for CXCR2 and CXCL1 on glia in multiple sclerosis. Glia 53:24-31.
45. Omari KM, John GR, Sealfon SC, Raine CS. 2005b. CXC chemokine receptors on human oligodendrocytes: Implications for multiple sclerosis. Brain 128 (Part 5):1003-1015.
46. Popko B. 2000. Myelin galactolipids: Mediators of axon-glial interactions? Glia 29:149-153.
47. Ragozzino D. 2002. CXC chemokine receptors in the central nervous system: Role in cerebellar neuromodulation and development. J Neurovirol 8:559-572.
48. Richardson WD, Kessaris N, Pringle N. 2006. Oligodendrocyte wars. Nat Rev Neurosci 7:11-18.
49. Robinson S, Cohen M, Prayson R, Ransohoff RM, Tabrizi N, Miller RH. 2001. Constitutive expression of growth-related oncogene and its receptor in oligodendrogliomas. Neurosurgery 48:864-873; discussion 873, 874.
50. Robinson S, Tani M, Strieter RM, Ransohoff RM, Miller RH. 1998. The chemokine growth-regulated oncogene-α promotes spinal cord oligodendrocyte precursor proliferation. J Neurosci 18:10457-10463.
51. Sherman DL, Brophy PJ. 2005. Mechanisms of axon ensheathment and myelin growth. Nat Rev Neurosci 6:683-690.
52. Sommer I, Schachner M. 1981. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: An immunocytological study in the central nervous system. Dev Biol 83:311-327.
53. Takashima S, Becker LE. 1984. Developmental neuropathology in bronchopulmonary dysplasia: Alteration of glial fibrillary acidic protein and myelination. Brain Dev 6:451-457.
54. Tecimer T, Dlott J, Chuntharapai A, Martin AW, Peiper SC. 2000. Expression of the chemokine receptor CXCR2 in normal and neoplastic neuroendocrine cells. Arch Pathol Lab Med 124:520-525.
55. Tran PB, Miller RJ. 2003. Chemokine receptors: Signposts to brain development and disease. Nat Rev Neurosci 4:444-455.
56. Tsai HH, Frost E, To V, Robinson S, Ffrench-Constant C, Geertman R, Ransohoff RM, Miller RH. 2002. The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell 110:373-383.
57. Tsai HH, Macklin WB, Miller RH. 2006. Netrin-1 is required for the normal development of spinal cord oligodendrocytes. J Neurosci 26:1913-1922.
58. Tsai HH, Miller RH. 2002. Glial cell migration directed by axon guidance cues. Trends Neurosci 25:173-175; discussion 175-176.
59. Warf BC, Fok-Seang J, Miller RH. 1991. Evidence for the ventral origin of oligodendrocyte precursors in the rat spinal cord. J Neurosci 11:2477-2488.
60. Watanabe M, Toyama Y, Nishiyama A. 2002. Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. J Neurosci Res 69:826-836.
61. Waxman SG. 1980. Determinants of conduction velocity in myelinated nerve fibers. Muscle Nerve 3:141-150.
62. Wu Q, Miller RH, Ransohoff RM, Robinson S, Bu J, Nishiyama A. 2000. Elevated levels of the chemokine GRO-1 correlate with elevated oligodendrocyte progenitor proliferation in the jimpy mutant. J Neurosci 20:2609-2617.